万春药业(BYSI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BYSI 万春药业

盘前交易 12-24 04:01:16 EST

1.86

-0.04

-2.11%

最高1.95	最低1.82	成交量8.76万
今开1.91	昨收1.90	日振幅6.61%
总市值7,649万	流通市值5,621万	总股本4,112万
成交额16.57万	换手率0.29%	流通股本3,022万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BYSI","market":"US","secType":"STK","nameCN":"万春药业","latestPrice":1.86,"timestamp":1766523600000,"preClose":1.9,"halted":0,"volume":87583,"delay":0,"floatShares":30219373,"shares":41122299,"eps":-0.014832,"marketStatus":"盘前交易","change":-0.04,"latestTime":"12-24 04:01:16 EST","open":1.91,"high":1.9456,"low":1.82,"amount":165669.0600112,"amplitude":0.066105,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.014832,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766586600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1489035600000,"exchange":"NASDAQ","adjPreClose":1.86,"postHourTrading":{"tag":"盘后","latestPrice":1.86,"preClose":1.86,"latestTime":"19:03 EST","volume":52,"amount":96.806,"timestamp":1766534627290},"volumeRatio":0.30757961268535533,"impliedVol":0.1089,"impliedVolPercentile":0.1767},"requestUrl":"/m/hq/s/BYSI","defaultTab":"news","newsList":[{"id":"1176633270","title":"万春药业公布Dublin-3 III期研究的新分析结果，显示Plinabulin + Docetaxel在抗Pd-(L)1治疗后对于非鳞状EGFR野生型NSCLC的生存获益，以及与Docetaxel相比脑转移减少情况，在NACLC 2025上发布","url":"https://stock-news.laohu8.com/highlight/detail?id=1176633270","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176633270?lang=zh_cn&edition=full","pubTime":"2025-12-11 20:07","pubTimestamp":1765454841,"startTime":"0","endTime":"0","summary":"万春药业公布Dublin-3 III期研究的新分析结果，显示Plinabulin + Docetaxel在抗Pd-(L)1治疗后对于非鳞状EGFR野生型NSCLC的生存获益，以及与Docetaxel相比脑转移减少情况，在NACLC 2025上发布","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BYSI","BK4139"],"gpt_icon":0},{"id":"2585948175","title":"万春医药盘中异动 急速上涨5.17%报1.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585948175","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585948175?lang=zh_cn&edition=full","pubTime":"2025-11-21 22:33","pubTimestamp":1763735621,"startTime":"0","endTime":"0","summary":"北京时间2025年11月21日22时33分，万春医药股票出现异动，股价快速拉升5.17%。截至发稿，该股报1.83美元/股，成交量6423股，换手率0.02%，振幅1.14%。万春医药股票所在的生物技术行业中，整体涨幅为0.08%。万春医药公司简介：BeyondSpring Inc从事临床阶段的生物制药活动，专注于癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121223342a4b1dbad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121223342a4b1dbad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BYSI","BK4139"],"gpt_icon":0},{"id":"2582348414","title":"万春医药盘中异动 下午盘股价大涨8.03%报2.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582348414","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582348414?lang=zh_cn&edition=full","pubTime":"2025-11-12 03:17","pubTimestamp":1762888671,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日03时17分，万春医药股票出现异动，股价大幅上涨8.03%。截至发稿，该股报2.09美元/股，成交量5567股，换手率0.01%，振幅5.18%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.81百万美元，每股收益-0.04美元，毛利-82000.00美元，市盈率-101.00倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体涨幅为1.47%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112031751a6f296df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112031751a6f296df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"gpt_icon":0},{"id":"2582883683","title":"万春医药盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582883683","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582883683?lang=zh_cn&edition=full","pubTime":"2025-11-10 22:42","pubTimestamp":1762785762,"startTime":"0","endTime":"0","summary":"北京时间2025年11月10日22时42分，万春医药股票出现波动，股价急速跳水5.10%。截至发稿，该股报1.86美元/股，成交量2468股，换手率0.01%，振幅0.26%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体涨幅为0.62%。万春医药公司简介：BeyondSpring Inc从事临床阶段的生物制药活动，专注于癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110224242a6efc314&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110224242a6efc314&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"gpt_icon":0},{"id":"2576565703","title":"万春医药盘中异动 股价大涨6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576565703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576565703?lang=zh_cn&edition=full","pubTime":"2025-10-16 21:39","pubTimestamp":1760621942,"startTime":"0","endTime":"0","summary":"北京时间2025年10月16日21时39分，万春医药股票出现异动，股价快速上涨6.06%。截至发稿，该股报1.75美元/股，成交量203股，换手率0.00%，振幅1.75%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体涨幅为0.65%。万春医药公司简介：BeyondSpring Inc从事临床阶段的生物制药活动，专注于癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016213902a6bd2214&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016213902a6bd2214&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BYSI","BK4139","PRAX"],"gpt_icon":0},{"id":"2557316958","title":"万春医药盘中异动 下午盘股价大跌6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557316958","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557316958?lang=zh_cn&edition=full","pubTime":"2025-08-06 02:24","pubTimestamp":1754418254,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日02时24分，万春医药股票出现波动，股价急速下挫6.02%。截至发稿，该股报2.03美元/股，成交量6920股，换手率0.02%，振幅4.17%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体跌幅为3.87%。万春医药公司简介：BeyondSpring Inc从事临床阶段的生物制药活动，专注于癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806022414a4770ea3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806022414a4770ea3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BYSI","STTK","BK4139"],"gpt_icon":0},{"id":"2556338346","title":"万春医药盘中异动 早盘股价大涨5.80%报2.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556338346","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556338346?lang=zh_cn&edition=full","pubTime":"2025-08-04 23:04","pubTimestamp":1754319871,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日23时04分，万春医药股票出现波动，股价快速拉升5.80%。截至发稿，该股报2.19美元/股，成交量9479股，换手率0.02%，振幅4.35%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体涨幅为0.68%。万春医药公司简介：BeyondSpring Inc从事临床阶段的生物制药活动，专注于癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804230431a6d2a550&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804230431a6d2a550&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BYSI","BK4139"],"gpt_icon":0},{"id":"2556084236","title":"万春医药8月1日成交额为7.93万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556084236","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556084236?lang=zh_cn&edition=full","pubTime":"2025-08-02 09:29","pubTimestamp":1754098163,"startTime":"0","endTime":"0","summary":"美东时间2025年8月1日，万春医药成交额为7.93万美元，成交额较昨日增加263.32%，当日成交量为3.89万股。万春医药于2025年8月1日涨0.98%，报2.07美元，该股过去5个交易日涨7.81%，年初至今涨26.99%，过去60日跌2.82%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-01|7.93万|263.32%|3.89万|#|2025-07-31|2.18万|-44.60%|1.07万|#|2025-07-30|3.94万|97.74%|1.99万|#|2025-07-29|1.99万|-23.74%|9966.00|#|2025-07-28|2.61万|41.97%|1.36万|BeyondSpring Inc从事临床阶段的生物制药活动，专注于癌症疗法的开发。它还专注于包括免疫肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802092934a6cea0cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802092934a6cea0cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"gpt_icon":0},{"id":"2556837755","title":"万春医药上涨2.22%，报2.075美元/股，总市值8365.64万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556837755","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556837755?lang=zh_cn&edition=full","pubTime":"2025-08-01 00:59","pubTimestamp":1753981141,"startTime":"0","endTime":"0","summary":"8月1日，万春医药盘中上涨2.22%，截至00:59，报2.075美元/股，成交9671.0美元，总市值8365.64万美元。财务数据显示，截至2024年06月30日，万春医药收入总额100.0万美元，同比增长14.29%；归母净利润-726.2万美元，同比增长42.91%。大事提醒：5月5日，万春医药将披露2024财年年报。资料显示，万春药业公司是一家处于全球临床阶段的生物制药公司,专注于新型癌症疗法,包括晚期肿瘤免疫药物的研发。公司成立于2013年,总部设立在美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080101030494c6c1e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080101030494c6c1e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"gpt_icon":0},{"id":"2555096508","title":"万春医药7月29日成交额为1.99万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555096508","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555096508?lang=zh_cn&edition=full","pubTime":"2025-07-30 09:31","pubTimestamp":1753839072,"startTime":"0","endTime":"0","summary":"美东时间2025年7月29日，万春医药成交额为1.99万美元，成交额较昨日减少23.74%，当日成交量为9966.00股。万春医药于2025年7月29日涨4.69%，报2.01美元，该股过去5个交易日涨7.49%，年初至今涨23.31%，过去60日涨12.29%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-29|1.99万|-23.74%|9966.00|#|2025-07-28|2.61万|41.97%|1.36万|#|2025-07-25|1.84万|-59.97%|9480.00|#|2025-07-24|4.60万|-63.19%|2.33万|#|2025-07-23|12.49万|-13.27%|6.76万|BeyondSpring Inc从事临床阶段的生物制药活动，专注于癌症疗法的开发。它还专注于包括免疫肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730093504a46a82a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730093504a46a82a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"gpt_icon":0},{"id":"2555053277","title":"万春医药上涨3.13%，报1.98美元/股，总市值7982.63万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555053277","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555053277?lang=zh_cn&edition=full","pubTime":"2025-07-29 01:24","pubTimestamp":1753723493,"startTime":"0","endTime":"0","summary":"7月29日，万春医药盘中上涨3.13%，截至01:24，报1.98美元/股，成交1.72万美元，总市值7982.63万美元。财务数据显示，截至2024年06月30日，万春医药收入总额100.0万美元，同比增长14.29%；归母净利润-726.2万美元，同比增长42.91%。大事提醒：5月5日，万春医药将披露2024财年年报。资料显示，万春药业公司是一家处于全球临床阶段的生物制药公司,专注于新型癌症疗法,包括晚期肿瘤免疫药物的研发。公司成立于2013年,总部设立在美国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072901310594bfc20e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072901310594bfc20e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BYSI","BK4139"],"gpt_icon":0},{"id":"2552458774","title":"万春医药7月17日成交额为14.64万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552458774","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552458774?lang=zh_cn&edition=full","pubTime":"2025-07-18 09:26","pubTimestamp":1752801998,"startTime":"0","endTime":"0","summary":"美东时间2025年7月17日，万春医药成交额为14.64万美元，成交额较昨日增加239.50%，当日成交量为6.65万股。万春医药于2025年7月17日跌0.45%，报2.2美元，该股过去5个交易日跌2.22%，年初至今涨34.97%，过去60日涨64.18%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-17|14.64万|239.50%|6.65万|#|2025-07-16|4.31万|190.93%|1.91万|#|2025-07-15|1.48万|-35.41%|6528.00|#|2025-07-14|2.30万|66.41%|9967.00|#|2025-07-11|1.38万|-3.97%|5938.00|BeyondSpring Inc从事临床阶段的生物制药活动，专注于癌症疗法的开发。它还专注于包括免疫肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718092643a6b0d911&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718092643a6b0d911&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"gpt_icon":0},{"id":"2552174796","title":"万春医药7月16日成交额为4.31万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552174796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552174796?lang=zh_cn&edition=full","pubTime":"2025-07-17 09:26","pubTimestamp":1752715580,"startTime":"0","endTime":"0","summary":"美东时间2025年7月16日，万春医药成交额为4.31万美元，成交额较昨日增加190.93%，当日成交量为1.91万股。万春医药于2025年7月16日跌4.33%，报2.21美元，该股过去5个交易日跌4.33%，年初至今涨35.58%，过去60日涨68.7%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-16|4.31万|190.93%|1.91万|#|2025-07-15|1.48万|-35.41%|6528.00|#|2025-07-14|2.30万|66.41%|9967.00|#|2025-07-11|1.38万|-3.97%|5938.00|#|2025-07-10|1.44万|-3.73%|6300.00|BeyondSpring Inc从事临床阶段的生物制药活动，专注于癌症疗法的开发。它还专注于包括免疫肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717092628a44fc375&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717092628a44fc375&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BYSI","BK4139"],"gpt_icon":0},{"id":"2550260321","title":"万春医药7月10日成交额为1.44万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550260321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550260321?lang=zh_cn&edition=full","pubTime":"2025-07-11 09:27","pubTimestamp":1752197246,"startTime":"0","endTime":"0","summary":"美东时间2025年7月10日，万春医药成交额为1.44万美元，成交额较昨日减少3.73%，当日成交量为6300.00股。万春医药于2025年7月10日跌2.6%，报2.25美元，该股过去5个交易日跌1.75%，年初至今涨38.04%，过去60日涨104.55%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-10|1.44万|-3.73%|6300.00|#|2025-07-09|1.49万|-79.29%|6513.00|#|2025-07-08|7.21万|-31.58%|3.17万|#|2025-07-07|10.53万|207.16%|4.56万|#|2025-07-03|3.43万|-13.10%|1.51万|BeyondSpring Inc从事临床阶段的生物制药活动，专注于癌症疗法的开发。它还专注于包括免疫肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711092728a6a29471&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711092728a6a29471&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BYSI","BK4139"],"gpt_icon":0},{"id":"2550066047","title":"万春医药7月9日成交额为1.49万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550066047","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550066047?lang=zh_cn&edition=full","pubTime":"2025-07-10 09:26","pubTimestamp":1752110782,"startTime":"0","endTime":"0","summary":"美东时间2025年7月9日，万春医药成交额为1.49万美元，成交额较昨日减少79.29%，当日成交量为6513.00股。万春医药于2025年7月9日涨4.52%，报2.31美元，该股过去5个交易日跌4.55%，年初至今涨41.72%，过去60日涨111.93%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-09|1.49万|-79.29%|6513.00|#|2025-07-08|7.21万|-31.58%|3.17万|#|2025-07-07|10.53万|207.16%|4.56万|#|2025-07-03|3.43万|-13.10%|1.51万|#|2025-07-02|3.95万|22.83%|1.66万|BeyondSpring Inc从事临床阶段的生物制药活动，专注于癌症疗法的开发。它还专注于包括免疫肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710092626a6a0693f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710092626a6a0693f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"gpt_icon":0},{"id":"2550527982","title":"万春医药盘中异动 大幅拉升5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550527982","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550527982?lang=zh_cn&edition=full","pubTime":"2025-07-09 02:05","pubTimestamp":1751997953,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日02时05分，万春医药股票出现异动，股价大幅上涨5.73%。截至发稿，该股报2.40美元/股，成交量6850股，换手率0.02%，振幅6.61%。万春医药股票所在的生物技术行业中，整体涨幅为1.08%。万春医药公司简介：BeyondSpring Inc从事临床阶段的生物制药活动，专注于癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709020553a43e86b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709020553a43e86b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLYB","BK4139","BK4539","BYSI"],"gpt_icon":0},{"id":"2549953003","title":"万春医药盘中异动 早盘股价大涨8.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549953003","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549953003?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:32","pubTimestamp":1751895125,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时32分，万春医药股票出现异动，股价急速上涨8.52%。截至发稿，该股报2.42美元/股，成交量8366股，换手率0.02%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体跌幅为0.09%。万春医药公司简介：BeyondSpring Inc从事临床阶段的生物制药活动，专注于癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213205a69b19aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213205a69b19aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BYSI","BK4139"],"gpt_icon":0},{"id":"2548133122","title":"万春医药7月3日成交额为3.43万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548133122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548133122?lang=zh_cn&edition=full","pubTime":"2025-07-04 09:26","pubTimestamp":1751592360,"startTime":"0","endTime":"0","summary":"美东时间2025年7月3日，万春医药成交额为3.43万美元，成交额较昨日减少13.10%，当日成交量为1.51万股。万春医药于2025年7月3日跌2.62%，报2.23美元，该股过去5个交易日跌11.51%，年初至今涨36.81%，过去60日涨93.91%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-03|3.43万|-13.10%|1.51万|#|2025-07-02|3.95万|22.83%|1.66万|#|2025-07-01|3.21万|-39.23%|1.32万|#|2025-06-30|5.29万|-34.85%|2.22万|#|2025-06-27|8.11万|66.17%|3.30万|BeyondSpring Inc从事临床阶段的生物制药活动，专注于癌症疗法的开发。它还专注于包括免疫肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704092608a72da844&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704092608a72da844&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"gpt_icon":0},{"id":"2548171818","title":"万春医药盘中异动 临近收盘股价大跌5.37%报2.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548171818","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548171818?lang=zh_cn&edition=full","pubTime":"2025-07-03 04:01","pubTimestamp":1751486512,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日04时01分，万春医药股票出现波动，股价快速下跌5.37%。截至发稿，该股报2.29美元/股，成交量1.6311万股，换手率0.04%，振幅6.61%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体涨幅为1.12%。万春医药公司简介：BeyondSpring Inc从事临床阶段的生物制药活动，专注于癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703040152a4cbbc89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703040152a4cbbc89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"gpt_icon":0},{"id":"2548886783","title":"万春医药盘中异动 股价大涨5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548886783","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548886783?lang=zh_cn&edition=full","pubTime":"2025-07-02 00:35","pubTimestamp":1751387706,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日00时35分，万春医药股票出现异动，股价快速拉升5.53%。截至发稿，该股报2.48美元/股，成交量2754股，换手率0.01%，振幅1.91%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体涨幅为1.07%。万春医药公司简介：BeyondSpring Inc从事临床阶段的生物制药活动，专注于癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507020035069532c7d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507020035069532c7d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beyondspringpharma.com","stockEarnings":[{"period":"1week","weight":-0.0606},{"period":"1month","weight":-0.0287},{"period":"3month","weight":0.1006},{"period":"6month","weight":-0.2619},{"period":"1year","weight":0.0629},{"period":"ytd","weight":0.1411}],"compareEarnings":[{"period":"1week","weight":0.0134},{"period":"1month","weight":0.0439},{"period":"3month","weight":0.0406},{"period":"6month","weight":0.1244},{"period":"1year","weight":0.1568},{"period":"ytd","weight":0.1738}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"万春医药公司于2014年11月21日在开曼群岛注册成立。该公司是一家处于全球临床阶段的生物制药公司,专注于新型癌症疗法，包括晚期肿瘤免疫药物的研发。在万春医药，其使命是利用他们的癌症治疗的学术及业务能力，采用独有方式来改变癌症治疗的现状。公司成立于2013年，总部设立在美国。他们的主要项目普那布林来源于天然化合物，由于所具有的各种生化活性，对多种癌症有治疗潜力。他们采用一种新颖的、高度可扩展的商业模式，整合美中优势资源，高效、低成本地实现药物的报批和开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.024795},{"month":2,"riseRate":0.5,"avgChangeRate":-0.048758},{"month":3,"riseRate":0.25,"avgChangeRate":0.104723},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.021214},{"month":5,"riseRate":0.666667,"avgChangeRate":0.086539},{"month":6,"riseRate":0.666667,"avgChangeRate":0.114713},{"month":7,"riseRate":0,"avgChangeRate":-0.133186},{"month":8,"riseRate":0.444444,"avgChangeRate":0.225863},{"month":9,"riseRate":0.555556,"avgChangeRate":-0.062538},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.066821},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.052314},{"month":12,"riseRate":0.444444,"avgChangeRate":0.152727}],"exchange":"NASDAQ","name":"万春药业","nameEN":"Beyondspring Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"万春药业(BYSI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供万春药业(BYSI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"万春药业,BYSI,万春药业股票,万春药业股票老虎,万春药业股票老虎国际,万春药业行情,万春药业股票行情,万春药业股价,万春药业股市,万春药业股票价格,万春药业股票交易,万春药业股票购买,万春药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"万春药业(BYSI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供万春药业(BYSI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}